A Global TIF Survey on HBV and HCV infections in thalassaemia

* 1. Haemoglobinopathy/ Thalassaemia clinic/ Transfusion Centre (whichever is appropriate for your country):

* 2. Is there a National Transfusion Service in your country?

* 3. Which authority is responsible for quality practices in blood banks?

* 4. Are there national guidelines for all blood services in your country to follow?

* 5. Is there a national (across the country) programme for the prevention of viral hepatitis?

* 6. What number and proportion out of the total number of your thalassaemia patients are infected with:

* 7. The highest proportion of my thalassaemia patients are infected with:

* 8. To date, the infected patients have received anti-viral treatment:

* 9. To date, what proportion of the infected patients have received anti-viral treatment:

* 10. What are the criteria for providing antiviral treatment to infected thalassaemia patients in your country?

* 11. Has your country revised/ upgraded the treatment protocols for HBV and HCV infections?

* 12. If yes, which drugs are registered and used in your country for HBV treatment?

* 13. If yes to question 9, which drugs are registered and used in your country for HCV treatment?

T